|Chennai||Rs. 25020.00 (0.81%)|
|Mumbai||Rs. 25890.00 (0.98%)|
|Delhi||Rs. 25200.00 (-0.2%)|
|Kolkata||Rs. 25480.00 (1.03%)|
|Kerala||Rs. 24800.00 (0.61%)|
|Bangalore||Rs. 25000.00 (0.81%)|
|Hyderabad||Rs. 25080.00 (1.09%)|
Hyderabad-based drug discovery research and development firm GVK Biosciences (GVK Bio) has entered into a collaboration agreement with US-based Endo Pharmaceuticals focused on discovering novel small molecules targeting a protein.
As per the agreement, GVK Bio will use its discovery expertise to deliver a clinical candidate and Endo will develop and commercialise the product arising out of this collaboration. The collaboration arose out of a newly-launched concept at GVK Bio named Early Discovery Assets (EDA).